Artificial Intelligence-Driven Multi-Omics Diagnostic Pipelines for Infectious, Neurodegenerative, and Metabolic Diseases: From Biomarker Discovery to Precision Medicine and Digital Twin Healthcare
Article Sidebar
Main Article Content
Abstract
The combination of AI and multi-omics has ushered in a new, revolutionary era in disease diagnosis and precision medicine. This review aims to summarize the current status of the artificial intelligence (AI)-based multi-omics diagnostic workflows employed in three disease paradigms: infectious, neurodegenerative, and metabolic diseases, and critically evaluate their translational potential from the discovery of biomarkers to digital twin healthcare systems. Machine Learning (ML) and Deep Learning (DL) algorithms, as well as Explainable Artificial Intelligence (XAI) algorithms, are explored for their application in linking genomics, transcriptomics, proteomics, metabolomics, and microbiomics datasets to enable high-dimensional molecular phenotyping. Harmonisation strategies for multi-omics data, AIdriven feature selection, molecular pathway elucidation using graph neural networks (GNNs) and transformer architectures, and the development of digital twin models for personalised, dynamic health simulation are among the key themes. We delve deeper into the regulatory, ethical, and equity issues arising from the deployment of AI-omics systems across heterogeneous clinical settings. The review ends with a strategy for integrating validated AI-omics pipelines into the next-generation precision therapeutics and global health infrastructure.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. DOI: http://doi.org/10.1016/S0140-6736(20)30925-9
Li Y, Wu X, Fang D, Luo Y. Informing immunotherapy with multi-omics driven machine learning. NPJ Digit Med. 2024;7(1):67.
DOI: http://doi.org/10.1038/s41746-024-01043-6
Ballard JL, Wang Z, Li W, Shen L, Long Q. Deep learning-based approaches for multi-omics data integration and analysis. BioData Min. 2024;17(1):38. DOI: http://doi.org/10.1186/s13040-024-00391-z
Tran KA, Kondrashova O, Bradley A, Williams ED, Pearson JV, Waddell N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med. 2021;13(1):152. DOI: http://doi.org/10.1186/s13073-021-00968-x
Yetgin A. Revolutionising multi-omics analysis with artificial intelligence and data processing. Quant Biol. 2025;13(3):e70002.
DOI: http://doi.org/10.1002/qub2.70002
Rieke N, Hancox J, Li W, et al. The future of digital health with federated learning. NPJ Digit Med. 2020;3(1):119.
DOI: http://doi.org/10.1038/s41746-020-00323-1
Katsoulakis E, Wang Q, Wu H, et al. Digital twins for health: a scoping review. NPJ Digit Med. 2024;7(1):77.
DOI: http://doi.org/10.1038/s41746-024-01073-0
Athieniti E, Spyrou GM. A guide to multi-omics data collection and integration for translational medicine. Comput Struct Biotechnol J. 2023;21:134–149. DOI: http://doi.org/10.1016/j.csbj.2022.11.050
Chen C, Wang J, Pan D, et al. Applications of multi-omics analysis in human diseases. MedComm. 2023;4(4):e315.
DOI: http://doi.org/10.1002/mco2.315
Sanches PHG, de Melo NC, Porcari AM, de Carvalho LM. Integrating molecular perspectives: strategies for comprehensive multi-omics integrative data analysis and machine learning applications in transcriptomics, proteomics, and metabolomics. Biology (Basel). 2024;13(11):848. DOI: http://doi.org/10.3390/biology13110848
Stokes JM, Yang K, Swanson K, et al. A deep learning approach to antibiotic discovery. Cell. 2020;180(4):688–702.
DOI: http://doi.org/10.1016/j.cell.2020.01.021
Moor M, Banerjee O, Abad ZSH, et al. Foundation models for generalist medical artificial intelligence. Nature. 2023;616(7956):259–265.
DOI: http://doi.org/10.1038/s41586-023-05881-4
Molla G, Bitew M. Revolutionising personalised medicine: synergy with multi-omics data generation, main hurdles, and future perspectives. Biomedicines. 2024;12(12):2750. DOI: http://doi.org/10.3390/biomedicines12122750
Zhou Y, Fan P, Zhang H, et al. multi-omics and machine learning identify novel biomarkers and therapeutic targets of COVID-19. Front Immunol. 2025;16:1671936. DOI: http://doi.org/10.3389/fimmu.2025.1671936
Cao S, Dhaliwal HK, Pan M, et al. Extracting a COVID-19 signature from a multi-omic dataset. Gigascience. 2025;14: giaf064.
DOI: http://doi.org/10.1093/gigascience/giaf064
Ren F, Wei J, Chen Q, et al. Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: progress, challenges, and future directions. Acta Pharm Sin B. 2025;15(8):3985–4009. DOI: http://doi.org/10.1016/j.apsb.2025.07.030
Eteleeb AM, Novotny BC, Soriano Tarraga C, et al. Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease. PLoS Biol. 2024;22(4):e3002607. DOI: http://doi.org/10.1371/journal.pbio.3002607
Christensen NJ, Lassen FH, Holm LA, et al. Identification of cross-diagnostic protein signatures and subtypes of neurodegenerative diseases using multi-task deep learning on the UK Biobank proteomics dataset. Alzheimer's Dement. 2025;21(1):e14381.
DOI: http://doi.org/10.1002/alz.%2014381
Leiherer A, Muendlein A, Mink S, et al. Machine-learning approach to metabolomic data predicts incidence of type 2 diabetes mellitus. Int J Mol Sci. 2024;25(10):5331. DOI: http://doi.org/10.3390/ijms25105331
Yagin FH, Al-Hashem F, Ahmad I, Ahmad F, Alkhateeb A. Pilot-study to explore metabolic signature of type 2 diabetes: a pipeline of tree-based machine learning and bioinformatics techniques for biomarkers discovery. Nutrients. 2024;16(10):1537.
DOI: http://doi.org/10.3390/nu16101537
Arslan AK, Yagin FH, Algarni A, Karaaslan E, Al-Hashem F, Ardigò LP. Enhancing type 2 diabetes mellitus prediction by integrating metabolomics and tree-based boosting approaches. Front Endocrinol. 2024; 15:1444282. DOI: http://doi.org/10.3389/fendo.2024.1444282
O'Connor LM, O'Connor BA, Lim SB, Zeng J, Lo CH. Integrative multi-omics and systems bioinformatics in translational neuroscience: a data mining perspective. J Proteome Res. 2023;22(3):660–684. DOI: http://doi.org/10.1021/acs.jproteome.2c00580
Rossi SL, Subramanian P, Bovenkamp DE. The future is precision medicine-guided diagnoses, preventions and treatments for neurodegenerative diseases. Front Ageing Neurosci. 2023; 15:1128619. DOI: http://doi.org/10.3389/fnagi.2023.1128619
Ahmad A, Imran M, Ahsan H. Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases. Pharmaceutics. 2023;15(6):1630. DOI: http://doi.org/10.3390/pharmaceutics15061630
Lunke S, Bouffler SE, Patel CV, et al. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nat Med. 2023;29(7):1681–1691. DOI: http://doi.org/10.1038/s41591-023-02401-9
Sabry Z, Arora HS, Chandrasekaran S, Wang Z. AI-driven drug discovery and repurposing using multi-omics for myocardial infarction and heart failure. Explor Med. 2025; 6:1001340. DOI: http://doi.org/10.37349/emed.2025.1001340
Jiménez A, Merino MJ, Parras J, Zazo S. Explainable drug repurposing via path-based knowledge graph completion. Sci Rep. 2024;14(1):16596. DOI: http://doi.org/1.10.1038/s41598-024-67163-x
Gimeno M, San José-Enériz E, Villar S, et al. Explainable artificial intelligence for precision medicine in acute myeloid leukaemia. Front Immunol. 2022; 13:977358. DOI: http://doi.org/10.3389/fimmu.2022.977358
Vallée A. Envisioning the future of personalised medicine: role and realities of digital twins. J Med Internet Res. 2024;26: e50204.
DOI: http://doi.org/10.2196/50204
Gilbert S, Drummond D, Cotte F, Ziemssen T. Digital twins in medicine: transition from theoretical concept to tool used in everyday care. Front Digit Health. 2025;7:1573727. DOI: http://doi.org/10.3389/fdgth.2025.1573727
Papachristou K, Katsakiori PF, Papadimitroulas P, Strigari L, Kagadis GC. Digital twins' advancements and applications in healthcare, towards precision medicine. J Pers Med. 2024;14(11):1101. DOI: http://doi.org/10.3390/jpm14111101
Wickramasinghe N, Ulapane N, Andargoli A, et al. Digital twins to enable better precision and personalized dementia care. JAMIA Open. 2022;5(3): ooac072. DOI: http://doi.org/10.1093/jamiaopen/ooac072
Surian NU, Batagov A, Wu A, et al. A digital twin model incorporating generalized metabolic fluxes to identify and predict chronic kidney disease in type 2 diabetes mellitus. NPJ Digit Med. 2024;7(1):140. DOI: http://doi.org/10.1038/s41746-024-01108-6
Bordukova M, Makarov N, Rodriguez-Esteban R, et al. Generative artificial intelligence empowers digital twins in drug discovery and clinical trials. Expert Opin Drug Discov. 2024;19(1):33–42. DOI: http://doi.org/10.1080/17460441.2023.2273839
Rudsari HK, Tseng B, Zhu H, et al. Digital twins in healthcare: a comprehensive review and future directions. Front Digit Health. 2025; 7:1633539. DOI: http://doi.org/10.3389/fdgth.2025.1633539